# HCA Healthcare (HCA) Q2 2026 earnings

Results filed 2026-07-14 for the quarter ended 2026-06-30. Source page: https://earnings.opennash.com/companies/hca/2026-q2/
Press release and documents: https://www.sec.gov/Archives/edgar/data/860730/000119312526302539/0001193125-26-302539-index.htm
> Summaries and transcripts are machine-generated and can contain errors.

## In brief

HCA Healthcare absorbed a wave of exchange coverage losses that pushed patients to uninsured status, even as ER and admissions volumes grew and Florida's new Medicaid directed payment program was approved.

Demand at HCA's hospitals stayed healthy: same facility admissions rose 2.5 percent and emergency room visits rose 3.6 percent. But the patient mix worsened, as people who lost health insurance exchange coverage largely became uninsured. Surgical volumes fell, with inpatient surgeries down 2.3 percent and outpatient surgeries down 3.4 percent. The Centers for Medicare and Medicaid Services approved a Florida state directed payment program, giving a Medicaid supplemental payment benefit.
Management is steering toward its plan to digitize and grow its healthcare networks, backed by capital spending of $5.0 billion to $5.5 billion, which is unchanged. It says it is gaining market share and that its Valesco acquisition gave it control of many hospital-based services. The main tension is policy: exchange losses are now expected to be larger, and future Medicaid payment approvals are excluded from guidance, so coverage and reimbursement rules remain outside management's control.

## Key numbers

| Metric | Value | Change | Basis |
| --- | --- | --- | --- |
| Revenue (preliminary) | $20.230 billion | compared to $18.605 billion in the second quarter of 2025 | GAAP |
| Net income attributable to HCA Healthcare (preliminary) | $1.699 billion | compared to $1.653 billion in the second quarter of 2025 | GAAP |
| Diluted EPS (preliminary) | $7.62 | compared to $6.83 in the second quarter of 2025 | GAAP |
| Diluted EPS, as adjusted (preliminary) | $7.59 | compared to $6.84 in the second quarter of 2025 | non-GAAP |
| Adjusted EBITDA (preliminary) | $4.027 billion | compared to $3.849 billion in the second quarter of 2025 | non-GAAP |

## Segments and operating metrics

| Name | Value | Change |
| --- | --- | --- |
| Same facility admissions | 2.5 percent | increase versus the prior year period |
| Same facility equivalent admissions | 2.7 percent | increase versus the prior year period |
| Same facility emergency room visits | 3.6 percent | increase versus the prior year period |
| Same facility inpatient surgeries | 2.3 percent | decline versus the prior year period |
| Same facility outpatient surgeries | 3.4 percent | decline versus the prior year period |

## Outlook

| Metric | Period | Outlook |
| --- | --- | --- |
| Revenues | 2026 | $77.000 to $79.500 billion |
| Net income attributable to HCA Healthcare | 2026 | $6.300 to $6.700 billion |
| Adjusted EBITDA | 2026 | $15.400 to $16.100 billion |
| Diluted EPS | 2026 | $28.70 to $30.50 per diluted share |
| Capital expenditures, excluding acquisitions | 2026 | $5.0 billion to $5.5 billion |
| Health insurance exchange payer mix impact on income before income taxes | 2026 | ($1.000) to ($1.200) billion |
| Incremental net benefit from Medicaid Supplemental Payment Programs | 2026 | $300 to $500 million |

## Key takeaways

1. **Exchange coverage losses are shifting patients to uninsured** Patients who lost health insurance exchange coverage drove an increase in uninsured volume, which HCA estimates cost about $400 million of pre-tax income in the quarter. Management raised its full-year exchange impact estimate to ($1.000) to ($1.200) billion from ($600) to ($900) million.
2. **Emergency room and admissions volumes kept growing** Same facility admissions rose 2.5 percent, equivalent admissions 2.7 percent and ER visits 3.6 percent. Demand for hospital care is holding up even as the payer mix deteriorates.
3. **Surgical volumes declined, creating a service mix shift** Same facility inpatient surgeries fell 2.3 percent and outpatient surgeries fell 3.4 percent. HCA cites this as a secondary mix headwind, since surgical services are a key part of its care portfolio.
4. **Florida directed payment approval reset Medicaid supplemental outlook** CMS approved a state directed payment program in Florida during the quarter, covering October 1, 2024 through June 30, 2026. HCA now expects a Medicaid Supplemental Payment Programs benefit of $300 to $500 million for 2026, versus a prior estimate of ($50) to ($250) million.
5. **Capacity investment and Valesco acquisition support growth strategy** HCA's capital spending plan of $5.0 billion to $5.5 billion is unchanged, and it points to its network digitization strategy. It also says the Valesco acquisition gave it control of many hospital-based services and that it is gaining market share in many markets.

## Questions

**What drove HCA's payer mix problem this quarter?** An increase in uninsured volume, mainly from patients who lost coverage on the health insurance exchanges. HCA estimates this cost about $400 million of pre-tax income in the quarter and now expects a $1.000 to $1.200 billion hit for 2026.
**How did patient volumes trend at HCA hospitals?** Demand grew in admissions, with same facility admissions up 2.5 percent and ER visits up 3.6 percent. Surgeries declined, with inpatient down 2.3 percent and outpatient down 3.4 percent.
**What happened with Medicaid supplemental payments?** CMS approved a Florida state directed payment program during the quarter, so HCA recognized about $400 million of incremental net benefit covering October 1, 2024 through June 30, 2026. Guidance excludes any future approvals of this kind.
**Is HCA changing its investment plans or strategy?** No. Its 2026 capital expenditure estimate of $5.0 billion to $5.5 billion is unchanged, and CEO Sam Hazen says it will keep executing its strategic plan to digitize and grow its healthcare networks.
**What is HCA saying about its competitive position?** Management says it believes it is gaining market share in many of its markets. It also says its Valesco acquisition gave it control of many of its hospitals' hospital-based services.

## Slides and investor documents

- [Webcast](https://events.q4inc.com/attendee/210598605) (Webcast replay)
- [Financial Statement](https://d18rn0p25nwr6d.cloudfront.net/CIK-0000860730/360a24a7-918d-416a-bb22-aec11306e5a4.pdf) (Document)

